Big news in the biotech world: the FDA is looking into the death of an 8-year-old who got Sarepta’s Elevidys gene therapy for muscular dystrophy. The twist? Roche, Sarepta’s partner, says the death wasn’t caused by the treatment. Still, after a string of serious incidents, both the FDA and Roche have paused shipments of Elevidys in several countries. The pressure is definitely on for Sarepta right now. #Health #BodyHealth #FDA